People
Geoffrey Joyce, PhD
Director, Health Policy, USC Schaeffer Center
Senior Scholar, USC Schaeffer Institute
Chair, Department of Pharmaceutical and Health Economics, USC Mann School
Professor, USC Mann School
Biography
Geoffrey Joyce is director of health policy at the USC Schaeffer Center for Health Policy & Economics, professor and chair of the Department of Pharmaceutical and Health Economics at USC Mann, and research associate at the National Bureau of Economic Research.
Joyce is the author of more than 125 peer-reviewed articles, reports and book chapters, and his research has been published in leading medical, economic, health policy and statistics journals. His work has been featured in the Wall Street Journal, the Washington Post, the Los Angeles Times, U.S. News & World Report, NBC Nightly News, CBS Evening News, National Public Radio and other media.
His research focuses on the costs of medical care and the role of insurance. He published a series of studies in JAMA examining the impact of alternative pharmacy benefit designs on prescription drug utilization and spending. Other studies by Joyce have examined the lifetime costs of chronic disease, smoking cessation, the cost-effectiveness of highly active antiretroviral therapy for HIV-infected patients, and differences in medical care utilization and costs under alternative financing arrangements and treatment settings. He received a Centers for Medicare & Medicaid Innovation grant that integrates clinical pharmacy into primary care and is currently examining the economic costs and impact of dementia.
Latest Research View All
In The News View All
Los Angeles Times
USC Schaeffer scholars quoted on the rollout of TrumpRx
Featured Experts: Geoffrey Joyce, Darius Lakdawalla
NPR
Joyce interviewed about White House deal lowering prices on anti-obesity medications
Featured Experts: Geoffrey Joyce
MarketWatch
Joyce explains why patients’ drug costs may vary from pharmacy to pharmacy
Featured Experts: Geoffrey Joyce
STAT
Joyce explains why Trump could more easily use Medicare negotiations, rather than most-favored nation, to slash drug prices
Featured Experts: Geoffrey Joyce
Associated Press
Joyce debunks President Trump’s claims that drugmakers are preparing to cut prices by 1,500 percent
Featured Experts: Geoffrey Joyce
NPR
Joyce says it will take more than tariffs to shift drug manufacturing back to the U.S.
Featured Experts: Geoffrey Joyce